Company data
BioCryst Pharmaceuticals, Inc. employees and revenue per employee
BCRX · Biotechnology · $2.31B market cap
BioCryst Pharmaceuticals, Inc. had 435 employees at the end of fiscal Dec 2025, down 25.0% from a year earlier. Revenue for the year was $875M, up 94.1% from a year earlier, or $2.01M per employee. Revenue held up or grew while headcount stayed flat or fell.
Employees
435
-25.0% YoY
Revenue
$875M
+94.1% YoY
Revenue / employee
$2.01M
Peer median $602K
Rank in industry
4 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 435 | $875M | $2.01M | -25.0% | +94.1% |
| Dec 2024 | 580 | $451M | $777K | +8.2% | +36.0% |
| Dec 2023 | 536 | $331M | $618K | +0.9% | +22.4% |
| Dec 2022 | 531 | $271M | $510K | +48.3% | +72.3% |
| Dec 2021 | 358 | $157M | $439K | +45.5% | +782.4% |
| Dec 2020 | 246 | $17.8M | $72K | +75.7% | -63.5% |
| Dec 2019 | 140 | $48.8M | $349K | +40.0% | +136.5% |
| Dec 2018 | 100 | $20.7M | $207K | +17.6% | -18.0% |
| Dec 2017 | 85 | $25.2M | $296K | +30.8% | -4.4% |
| Dec 2016 | 65 | $26.4M | $405K | — | — |
Open roles: we have not matched a verified job board for this company yet.
BioCryst Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| MDGL Madrigal Pharmaceuticals, Inc. | 915 | $958M | $1.05M | Efficient growth |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| IONS Ionis Pharmaceuticals, Inc. | 1,402 | $944M | $673K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| TECH Bio-Techne Corporation | 3,000 | $1.22B | $405K | Contracting |
| LEGN Legend Biotech Corporation | 2,900 | $1.03B | $355K | Efficient growth |
Questions about BioCryst Pharmaceuticals, Inc.
- How many employees does BioCryst Pharmaceuticals, Inc. have?
- BioCryst Pharmaceuticals, Inc. reported 435 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is down 25.0% from a year earlier.
- What is BioCryst Pharmaceuticals, Inc.'s revenue per employee?
- BioCryst Pharmaceuticals, Inc. brought in $875M of revenue in fiscal Dec 2025, which is $2.01M per employee. That ranks 4 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare BCRX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in BioCryst Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell BCRX.